CASTLE BIOSCIENCES INC (CSTL)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for CSTL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CSTL | CEO and President; Class I Director | 61 | ["Previously served as the North American President and General Manager at Galderma Laboratories, L.P.","Also served as Galderma’s Vice President and General Manager of the Consumer Business Unit","Holds a B.S. degree in geography from Sheffield Hallam University in the United Kingdom","Commercial Execution Experience","Life Science Industry Experience","Financial Analysis & Control Experience","Experience in dermatology","Strategic leadership skills","Executive in the pharmaceutical and consumer healthcare industry","Co-founder of medical aesthetics company 'Novaestiq'","Former North American President and General Manager of Galderma Laboratories, L.P.","Leadership positions at Novartis International AG","Digital Health","Health System (HE) Experience","Regulatory/Lab Services Reimbursement"] | ["Comp. Committee","Nominating and Corporate Governance Committee","Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Miles has served as a member of our board of directors since April 2020 and as Chair of the Compensation Committee from 2020 through 2025. In October 2025, Miles accepted the role of CEO and President of Conexeu Sciences Inc. a pre-clinical company focused on building a new class of regenerative tissue therapies. From April 2021 through July 2025 Miles co-founded a medical aesthetics company Novaestiq which was acquired by Waldencast (WALD) 4 years later. Earlier, from 2016 through 2021, Miles spent 5 years as the North American President and General Manager of Galderma Laboratories, L.P., a global dermatology company. During his tenure at Galderma, he managed multiple launches across the company s pure-play dermatology portfolio (Rx, Consumer and Aesthetics) and helped shape strategy as a member of the Global Leadership Team. Prior to being President, Mr. Harrison served as Galderma s U.S. VP and General Manager of the Consumer Business from 2014, launching several brands and completing the first Rx to OTC switch in acne in the U.S. for more than 30 years. Mr. Harrison spent most of his career at Novartis International AG, a global healthcare company based in Basle, Switzerland. From 1987 to 2014, Mr. Harrison held multiple leadership positions of increasing responsibility at Novartis across Consumer Health, Oncology, Nutrition and Pharmaceuticals in operational and functional leadership roles. Mr. Harrison holds an Honors Degree in Geography from Sheffield Hallam University in the United Kingdom, and has lived and worked in the U.K., Europe, Middle East, Latin America, and the past 20+ years in the U.S. Independent Director Age: 61 Director since: 2020 Committees: Compensation Committee Nominating and Corporate Governance Committee Our Nominating and Corporate Governance Committee and board of directors believe Mr. Harrison s experience in dermatology combined with his strategic leadership skills, as an executive in the pharmaceutical and consumer healthcare industry , qualify him to serve on our board of directors.